Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis – GlobeNewswire (press release)

Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male OsteoporosisGlobeNewswire (press release)The primary endpoint of the male osteoporosis study is change in lumbar spine bone mineral density (BMD) at 12 months compared with placebo. The randomized, double-blind, placebo-controlled trial will enroll approximately 225 men with osteoporosis …

Source:: Osteoporosis Feed

      

Last modified: March 30, 2018